...
首页> 外文期刊>Journal of Young Pharmacists >Clinical Pharmacist’s Interventions on Medication Adherence and Knowledge of Inflammatory Bowel Disease Patients
【24h】

Clinical Pharmacist’s Interventions on Medication Adherence and Knowledge of Inflammatory Bowel Disease Patients

机译:临床药剂师对炎症性肠病患者用药依从性和知识的干预

获取原文
           

摘要

Objective: To evaluate whether clinical pharmacist’s interventions have any impact on medication adherence of patients having inflammatory bowel disease and to assess the awareness of patients about their disease and the significance of medications they use. Materials and Methods: A prospective, interventional follow up study was conducted in the outpatients visiting Gastroenterology and Hepatology department of Amrita Institute of Medical Sciences, Kochi. To assess the level of medication adherence and patient’s awareness, MMAS-8 and CCKNOW has been utilized. Once this baseline information’s were collected, counselling was given to patients and they were supplemented with pill cards and patient information leaflets as educational material. During the follow up visit, all the above parameters were reassessed and compared with the baseline visit. Result: About 110 IBD patients have participated in this study. In baseline visit, 6.36% patients had low adherence, 62.73% patients had medium adherence, 30.91% patients had high adherence. During follow up visit, after intervention by clinical pharamcist, 3.64% patients had low adherence, 18.18% patients had medium adherence and 78.18 % patients had high adherence. From this study, it was notified that the average score of CCKNOW was only 8.15 in the beginning. Later on, it was escalated to 11.65 during the revisit periods. Conclusion: Knowledge of patients about their disease and medications were insufficient during baseline visit. Adherence to medication was found to be poor among IBD patients. Counselling provided by clinical pharmacist about the importance of medication adherence and provision of information leaflets and pill cards lead to an improvement in medication adherence and knowledge of IBD patients.
机译:目的:评估临床药剂师的干预措施是否对炎症性肠病患者的用药依从性产生影响,并评估患者对其疾病的认识以及所用药物的重要性。资料与方法:前瞻性,干预性随访研究是在高知市阿姆里塔医学研究所胃肠病和肝病科门诊进行的。为了评估药物依从性水平和患者的意识,已使用MMAS-8和CCKNOW。一旦收集了这些基本信息,便会为患者提供咨询,并为他们提供药丸卡和患者信息单张作为教学材料。在随访期间,对上述所有参数进行了重新评估,并与基线随访进行了比较。结果:约110名IBD患者参加了这项研究。在基线访视中,6.36%的患者具有低依从性,62.73%的患者具有中等依从性,30.91%的患者具有高依从性。随访期间,经临床法医干预后,依从性低的患者为3.64%,中度依从的为18.18%,高依从性的为78.18%。从这项研究中可以得知,CCKNOW的平均评分在开始时仅为8.15。后来,在重新访问期间它被提升到11.65。结论:基线访视期间患者对疾病和药物的了解不足。发现IBD患者对药物的依从性差。临床药剂师提供的有关药物依从性的重要性的咨询以及提供信息传单和药丸卡的咨询可改善药物依从性和IBD患者的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号